Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2022 Filed May 5, 2022 21:23 UTC |
HELLMAN PETER SDirector
|
GrantCommon Stock, $1 par value | 2,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011686 · form4.xml · nonDerivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,335 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| May 03, 2022 Filed May 5, 2022 21:22 UTC |
Chen Thomas FDirector
|
GrantCommon Stock, $1 par value | 2,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011684 · form4.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,740 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC |
STROUCKEN ALBERT P LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,020 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · derivative · entry 5 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,020 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC |
STROUCKEN ALBERT P LDirector
|
SaleCommon Stock, $1 par value | 1,215 | $76.63 | $93,105.45 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · nonDerivative · entry 3 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,127 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $76.33 through $76.76. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC |
STROUCKEN ALBERT P LDirector
|
SaleCommon Stock, $1 par value | 2,805 | $75.76 | $212,506.80 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,342 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $75.32 through $76.30. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC |
STROUCKEN ALBERT P LDirector
|
Exercise / conversionCommon Stock, $1 par value | 4,020 | $29.52 | $118,670.40 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:05 UTC |
HELLMAN PETER SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,020 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001062993-22-009942 · form4.xml · derivative · entry 5 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,020 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Hellman on March 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Hellman which were scheduled to expire on May 8, 2022. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:05 UTC |
HELLMAN PETER SDirector
|
SaleCommon Stock, $1 par value | 1,193 | $76.63 | $91,419.59 |
DisclosureSEC source: 0001062993-22-009942 · form4.xml · nonDerivative · entry 3 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,629 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Hellman on March 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Hellman which were scheduled to expire on May 8, 2022. F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $76.33 through $76.81. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:05 UTC |
HELLMAN PETER SDirector
|
SaleCommon Stock, $1 par value | 2,827 | $75.76 | $214,173.52 |
DisclosureSEC source: 0001062993-22-009942 · form4.xml · nonDerivative · entry 2 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,822 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Hellman on March 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Hellman which were scheduled to expire on May 8, 2022. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $75.32 through $76.30. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:05 UTC |
HELLMAN PETER SDirector
|
Exercise / conversionCommon Stock, $1 par value | 4,020 | $29.52 | $118,670.40 |
DisclosureSEC source: 0001062993-22-009942 · form4.xml · nonDerivative · entry 1 HELLMAN PETER S · CIK 0001107468 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Hellman on March 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Hellman which were scheduled to expire on May 8, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,005 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001062993-22-009782 · form4.xml · derivative · entry 3 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005 Underlying: Common Stock, $1 par value · 1,005 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Forsyth November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth which were scheduled to expire on May 8, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC |
FORSYTH JOHN DDirector
|
SaleCommon Stock, $1 par value | 1,005 | $77.68 | $78,068.40 |
DisclosureSEC source: 0001062993-22-009782 · form4.xml · nonDerivative · entry 2 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,029 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Forsyth November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth which were scheduled to expire on May 8, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:57 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionCommon Stock, $1 par value | 1,005 | $29.52 | $29,667.60 |
DisclosureSEC source: 0001062993-22-009782 · form4.xml · nonDerivative · entry 1 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Forsyth November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth which were scheduled to expire on May 8, 2022. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:18 UTC |
Stevens BrianSVP, CAO and Controller
|
Tax withholdingCommon Stock, $1 par value | 157 | $79.05 | $12,410.85 |
DisclosureSEC source: 0001062993-22-008416 · form4.xml · nonDerivative · entry 1 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,993 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 21, 2022 from the settlement of vested restricted stock units granted on March 20, 2020. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 22:25 UTC |
Stevens BrianSVP, CAO and Controller
|
Tax withholdingCommon Stock, $1 par value | 172 | $85.19 | $14,652.68 |
DisclosureSEC source: 0001062993-22-006917 · form4.xml · nonDerivative · entry 4 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,151 F4 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2022 from the settlement of vested restricted stock units granted on March 3, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 22:25 UTC |
Stevens BrianSVP, CAO and Controller
|
GrantStock Option (Right to Buy) · Derivative | 8,269 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006917 · form4.xml · derivative · entry 5 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,269 Underlying: Common Stock, $1 par value · 8,269 shares Expires 2032-03-02 F5 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 22:25 UTC |
Stevens BrianSVP, CAO and Controller
|
GrantCommon Stock, $1 par value | 8,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006917 · form4.xml · nonDerivative · entry 3 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,324 F3 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest on March 3, 2025, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 22:25 UTC |
Stevens BrianSVP, CAO and Controller
|
GrantCommon Stock, $1 par value | 3,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006917 · form4.xml · nonDerivative · entry 2 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,406 F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:11 UTC |
SACCARO JAMESEVP, Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,613 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006854 · form4.xml · derivative · entry 2 SACCARO JAMES · CIK 0001593636 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,613 Underlying: Common Stock, $1 par value · 49,613 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:11 UTC |
SACCARO JAMESEVP, Chief Financial Officer
|
GrantCommon Stock, $1 par value | 10,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006854 · form4.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,276 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:10 UTC |
Martin SeanSVP and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 31,008 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006850 · form4.xml · derivative · entry 2 Martin Sean · CIK 0001500332 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,008 Underlying: Common Stock, $1 par value · 31,008 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:10 UTC |
Martin SeanSVP and General Counsel
|
GrantCommon Stock, $1 par value | 6,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006850 · form4.xml · nonDerivative · entry 1 Martin Sean · CIK 0001500332 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,632 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:10 UTC |
Mason Jeanne KSVP, Human Resources
|
GrantStock Option (Right to Buy) · Derivative | 23,428 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006852 · form4.xml · derivative · entry 2 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,428 Underlying: Common Stock, $1 par value · 23,428 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:10 UTC |
Mason Jeanne KSVP, Human Resources
|
GrantCommon Stock, $1 par value | 5,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006852 · form4.xml · nonDerivative · entry 1 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,153 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:09 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,781 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006848 · form4.xml · derivative · entry 2 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,781 Underlying: Common Stock, $1 par value · 13,781 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:09 UTC |
Kunzler JacquelineSVP, Chief Quality Officer
|
GrantCommon Stock, $1 par value | 2,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006848 · form4.xml · nonDerivative · entry 1 Kunzler Jacqueline · CIK 0001779771 · SVP, Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,976 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:08 UTC |
Frye AndrewSVP, President, APAC
|
GrantStock Option (Right to Buy) · Derivative | 34,454 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006846 · form4.xml · derivative · entry 2 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,454 Underlying: Common Stock, $1 par value · 34,454 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:08 UTC |
Frye AndrewSVP, President, APAC
|
GrantCommon Stock, $1 par value | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006846 · form4.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,002 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:07 UTC |
Franzi CristianoSVP, President, EMEA
|
GrantStock Option (Right to Buy) · Derivative | 37,899 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006844 · form4.xml · derivative · entry 2 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,899 Underlying: Common Stock, $1 par value · 37,899 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:07 UTC |
Franzi CristianoSVP, President, EMEA
|
GrantCommon Stock, $1 par value | 8,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006844 · form4.xml · nonDerivative · entry 1 Franzi Cristiano · CIK 0001715790 · SVP, President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,365 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:06 UTC |
ALMEIDA JOSE EChairman, CEO and President
|
GrantStock Option (Right to Buy) · Derivative | 151,596 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006840 · form4.xml · derivative · entry 2 ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,596 Underlying: Common Stock, $1 par value · 151,596 shares Expires 2032-03-02 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:06 UTC |
ALMEIDA JOSE EChairman, CEO and President
|
GrantCommon Stock, $1 par value | 32,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006840 · form4.xml · nonDerivative · entry 1 ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,435 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:07 UTC |
Borzi James WSVP, Global Supply Chain
|
GrantStock Option (Right to Buy) · Derivative | 19,294 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006842 · form4.xml · derivative · entry 2 Borzi James W · CIK 0001495559 · SVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,294 Underlying: Common Stock, $1 par value · 19,294 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:07 UTC |
Borzi James WSVP, Global Supply Chain
|
GrantCommon Stock, $1 par value | 4,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006842 · form4.xml · nonDerivative · entry 1 Borzi James W · CIK 0001495559 · SVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,356 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:05 UTC |
Accogli GiuseppeEVP, Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 55,126 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006838 · form4.xml · derivative · entry 2 Accogli Giuseppe · CIK 0001678067 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,126 Underlying: Common Stock, $1 par value · 55,126 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:05 UTC |
Accogli GiuseppeEVP, Chief Operating Officer
|
GrantCommon Stock, $1 par value | 11,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006838 · form4.xml · nonDerivative · entry 1 Accogli Giuseppe · CIK 0001678067 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,495 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,005 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001062993-22-006635 · form4.xml · derivative · entry 3 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,010 Underlying: Common Stock, $1 par value · 1,005 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Forsyth on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth which are scheduled to expire on May 8, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC |
FORSYTH JOHN DDirector
|
SaleCommon Stock, $1 par value | 1,005 | $84.82 | $85,244.10 |
DisclosureSEC source: 0001062993-22-006635 · form4.xml · nonDerivative · entry 2 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,029 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Forsyth on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth which are scheduled to expire on May 8, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC |
FORSYTH JOHN DDirector
|
Exercise / conversionCommon Stock, $1 par value | 1,005 | $29.52 | $29,667.60 |
DisclosureSEC source: 0001062993-22-006635 · form4.xml · nonDerivative · entry 1 FORSYTH JOHN D · CIK 0001262931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Forsyth on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Forsyth which are scheduled to expire on May 8, 2022. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:13 UTC |
Stevens BrianSVP, CAO and Controller
|
SaleCommon Stock, $1 par value | 175 | $86.07 | $15,062.25 |
DisclosureSEC source: 0001062993-22-006087 · form4.xml · nonDerivative · entry 2 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,011 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stevens on November 2, 2021 with respect to certain vested restricted stock units previously granted by Baxter International Inc. to Mr. Stevens. F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $85.06 through $85.07. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:13 UTC |
Stevens BrianSVP, CAO and Controller
|
SaleCommon Stock, $1 par value | 2,325 | $85.46 | $198,694.50 |
DisclosureSEC source: 0001062993-22-006087 · form4.xml · nonDerivative · entry 1 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,186 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stevens on November 2, 2021 with respect to certain vested restricted stock units previously granted by Baxter International Inc. to Mr. Stevens. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $85.00 through $85.95. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| February 28, 2022 Filed Mar 4, 2022 22:25 UTC |
Stevens BrianSVP, CAO and Controller
|
Tax withholdingCommon Stock, $1 par value | 172 | $84.97 | $14,614.84 |
DisclosureSEC source: 0001062993-22-006917 · form4.xml · nonDerivative · entry 1 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,839 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on February 28, 2022 from the settlement of vested restricted stock units granted on February 28, 2019. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:05 UTC |
Mason Jeanne KSVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,048 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001062993-22-004583 · form4.xml · derivative · entry 6 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 18,048 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Ms. Mason on November 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Ms. Mason which were scheduled to expire on March 6, 2022. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:05 UTC |
Mason Jeanne KSVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,048 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001062993-22-004583 · form4.xml · derivative · entry 5 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,048 Underlying: Common Stock, $1 par value · 18,048 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Ms. Mason on November 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Ms. Mason which were scheduled to expire on March 6, 2022. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:05 UTC |
Mason Jeanne KSVP, Human Resources
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,047 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001062993-22-004583 · form4.xml · derivative · entry 4 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,096 Underlying: Common Stock, $1 par value · 18,047 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Ms. Mason on November 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Ms. Mason which were scheduled to expire on March 6, 2022. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:05 UTC |
Mason Jeanne KSVP, Human Resources
|
SaleCommon Stock, $1 par value | 18,302 | $85.54 | $1,565,553.08 |
DisclosureSEC source: 0001062993-22-004583 · form4.xml · nonDerivative · entry 3 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,099 F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $85.44 through $85.62. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:05 UTC |
Mason Jeanne KSVP, Human Resources
|
SaleCommon Stock, $1 par value | 35,841 | $84.75 | $3,037,524.75 |
DisclosureSEC source: 0001062993-22-004583 · form4.xml · nonDerivative · entry 2 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,401 F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $84.37 through $85.26. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:05 UTC |
Mason Jeanne KSVP, Human Resources
|
Exercise / conversionCommon Stock, $1 par value | 54,143 | $30.95 | $1,675,725.85 |
DisclosureSEC source: 0001062993-22-004583 · form4.xml · nonDerivative · entry 1 Mason Jeanne K · CIK 0001362109 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Ms. Mason on November 5, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Ms. Mason which were scheduled to expire on March 6, 2022. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC |
Stevens BrianSVP, CAO and Controller
|
Tax withholdingCommon Stock, $1 par value | 468 | $87.75 | $41,067.00 |
DisclosureSEC source: 0001062993-22-004285 · form4.xml · nonDerivative · entry 3 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,511 F3 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of shares in 2019, 2020, and 2021 as part of the 2019 PSUs. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC |
Stevens BrianSVP, CAO and Controller
|
GrantCommon Stock, $1 par value | 724 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004285 · form4.xml · nonDerivative · entry 2 Stevens Brian · CIK 0001557559 · SVP, CAO and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,979 F2 · shares: Represents shares awarded from the 2019 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.